Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Veraxa Biotech AG (VRXA)

1.0300 -0.1100 (-9.65%)
At close: November 2 at 4:00:01 PM EST
1.0800 +0.0500 (+4.85%)
After hours: November 2 at 4:39:10 PM EST
View in AlphaSpace Currency in CHF All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
Total Revenue
23.4260
23.4260
0
0
Cost of Revenue
7.9650
7.9650
0
--
Gross Profit
15.4610
15.4610
0
--
Operating Expense
66,232.0360
66,232.0360
28,917.8810
16,659.9930
Operating Income
-66,216.5750
-66,216.5750
-28,917.8810
-16,659.9930
Net Non Operating Interest Income Expense
-3.5520
-3.5520
-0.2910
-1.0900
Other Income Expense
-786.4660
-786.4660
164.4270
-995.2250
Pretax Income
-67,006.5930
-67,006.5930
-28,753.7450
-17,656.3080
Tax Provision
-392.6030
-392.6030
-620.7740
-1,112.0700
Net Income Common Stockholders
-66,613.9900
-66,613.9900
-28,132.9710
-16,544.2380
Diluted NI Available to Com Stockholders
-66,613.9900
-66,613.9900
-28,132.9710
-16,544.2380
Basic EPS
-0.47
--
-0.20
-0.12
Diluted EPS
-0.47
--
-0.20
-0.12
Basic Average Shares
141,407.8130
--
141,407.8130
141,407.8130
Diluted Average Shares
141,407.8130
--
141,407.8130
141,407.8130
Total Operating Income as Reported
-66,216.5750
-66,216.5750
-28,917.8810
-16,659.9930
Total Expenses
66,240.0010
66,240.0010
28,917.8810
16,659.9930
Net Income from Continuing & Discontinued Operation
-66,613.9900
-66,613.9900
-28,132.9710
-16,544.2380
Normalized Income
-65,778.2029
-65,778.2029
-28,279.3569
-15,560.7707
Interest Expense
3.5520
3.5520
0.2910
1.0900
Net Interest Income
-3.5520
-3.5520
-0.2910
-1.0900
EBIT
-67,003.0410
-67,003.0410
-28,753.4540
-17,655.2180
EBITDA
-64,905.8160
-64,905.8160
-26,876.9720
-15,805.0350
Reconciled Cost of Revenue
132.6360
132.6360
0
--
Reconciled Depreciation
1,972.5540
1,972.5540
1,876.4820
1,850.1830
Net Income from Continuing Operation Net Minority Interest
-66,613.9900
-66,613.9900
-28,132.9710
-16,544.2380
Total Unusual Items Excluding Goodwill
-840.7130
-840.7130
149.6160
-1,049.5740
Total Unusual Items
-840.7130
-840.7130
149.6160
-1,049.5740
Normalized EBITDA
-64,065.1030
-64,065.1030
-27,026.5880
-14,755.4610
Tax Rate for Calcs
0
0
0
0.0001
Tax Effect of Unusual Items
-4.9259
-4.9259
3.2301
-66.1067
12/31/2023 - 9/30/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: